Medical Pharmaceutical Supply – Bupivacaine Hydrochloride Injection

The contract involves the supply and delivery of Bupivacaine Hydrochloride Injection, USP 0.5% in 50 mL vials to Fort Stewart, Georgia, under a subcontract arrangement managed by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. The product must meet all FDA compliance requirements and adhere to strict military packaging and labeling standards to ensure compatibility with DoD logistics and medical protocols. Delivery timelines are critical, with bids required by July 29, 2026, and the solicitation was posted on July 23, 2026, indicating a short turnaround for potential suppliers. The NAICS code 325412 confirms this is a pharmaceutical manufacturing and distribution opportunity, ensuring only qualified manufacturers with appropriate FDA certifications and military supply chain experience may respond. All goods must be delivered to the designated performance location and meet rigorous quality control benchmarks to maintain readiness and patient safety for military medical operations.